Merck KGaA is focusing on the integration of Sigma-Aldrich Corp. following its $17 billion purchase and secondly on developing its pharmaceutical pipeline, according to Chief Financial Officer Marcus Kuhnert. He spoke in an interview with Anna Edwards on Bloomberg Television's "Countdown."
ENJOY GREECE
We Explore, Find, Check & Propose You for the Truth - Enjoy GREECE - Enjoy EUROPE - Enjoy WORLD
